These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2490762)

  • 1. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
    Mojaverian P; Green PJ; Jhangiania RK; Chase GD
    J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New enzyme-linked immunosorbent digoxin assay on the ADVIA IMS 800i system is virtually free from interference of endogenous digoxin-like immunoreactive factors.
    Dasgupta A; Kang E; Datta P
    Ther Drug Monit; 2005 Apr; 27(2):139-43. PubMed ID: 15795642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digitalis-like immunoreactive substances in maternal and umbilical cord plasma: a comparative sensitivity study of fluorescence polarization immunoassay and microparticle enzyme immunoassay.
    Ijiri Y; Hayashi T; Kamegai H; Ohi K; Suzuki K; Kitaura Y; Takenaka H
    Ther Drug Monit; 2003 Apr; 25(2):234-9. PubMed ID: 12657920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference from digitoxin-like immunoreactive factors reduced in a new monoclonal chemiluminescent digitoxin assay.
    Datta P; Dasgupta A
    Ther Drug Monit; 1998 Dec; 20(6):663-8. PubMed ID: 9853984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and comparison of the TDxII, Stratus, and OPUS digoxin assays.
    Dodds HM; Norris RL; Johnson AG; Pond SM
    Ther Drug Monit; 1995 Feb; 17(1):68-74. PubMed ID: 7725380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Chem; 1986 Jan; 32(1 Pt 1):97-100. PubMed ID: 3753588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.
    Morris RG; Frewin DB; Saccoia NC; Goldsworthy WL; Jeffries WS; McPhee AJ
    Eur J Clin Pharmacol; 1990; 39(4):359-63. PubMed ID: 2076718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
    Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
    Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-multiplied immunoassay (EMIT 2000) digoxin assay compared with fluorescence polarization immunoassay and amerlex 125I-radioimmunoassay at two Australian centers.
    Saccoia NC; Hackett LP; Morris RG; Ilett KF
    Ther Drug Monit; 1996 Dec; 18(6):672-7. PubMed ID: 8946664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay. Elimination of negative interference by monitoring free digoxin concentrations.
    Dasgupta A; Trejo O
    Am J Clin Pathol; 1999 Mar; 111(3):406-10. PubMed ID: 10078117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digitoxinlike and digoxinlike immunoreactivitis in sera of patients with uremia and liver disease as measured by fluorescence polarization immunoassays: poor correlation between digitoxinlike and digoxinlike immunoreactivities.
    Luke M; Dasgupta A
    Ther Drug Monit; 1997 Apr; 19(2):230-5. PubMed ID: 9108656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin-like immunoreactive substance in renal transplant patients.
    Schrader BJ; Maddux MS; Veremis SA; Mozes MF; Maturen A; Bauman JL
    J Clin Pharmacol; 1991 Dec; 31(12):1126-31. PubMed ID: 1662232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants.
    Ng PK; LeGatt D; Coates J; Collins-Nakai RL
    Am J Hosp Pharm; 1985 Sep; 42(9):1977-9. PubMed ID: 3901741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of digoxinlike immunoreactive substances and digoxin FAB antibodies on the new digoxin microparticle enzyme immunoassay.
    Crossey MJ; Dasgupta A
    Ther Drug Monit; 1997 Apr; 19(2):185-90. PubMed ID: 9108648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum level of digoxin-like immunoreactive substances in newborn infants in the first two weeks of life, in umbilical cord blood and in pregnant patients at the time of labor].
    Gawaz MP; Schreiber R; Vogt W; Genz T; Kellner M
    Klin Padiatr; 1990; 202(1):31-6. PubMed ID: 2156105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of microparticle enzyme and fluorescence polarization immunoassays in pediatric patients not receiving digoxin.
    Chicella M; Branim B; Lee KR; Phelps SJ
    Ther Drug Monit; 1998 Jun; 20(3):347-51. PubMed ID: 9631935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference of endogenous digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA 1650 analyzer.
    Datta P; Dasgupta A
    Ther Drug Monit; 2004 Feb; 26(1):85-9. PubMed ID: 14749555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.
    Lackner TE; Lau BW; Parvin C; Valdes R
    Clin Pharm; 1988 Jun; 7(6):449-53. PubMed ID: 3402180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inaccuracies in digoxin measurement.
    Cook JD; Koch TR; Cook MS; Knoblock EC
    Clin Biochem; 1988 Dec; 21(6):353-7. PubMed ID: 3233747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.